|
GB191115253A
(en)
|
1911-06-30 |
1912-06-20 |
Adolph Schneider |
Improvements in Bottle-filling Machines.
|
|
US2382696A
(en)
|
1939-04-01 |
1945-08-14 |
Milleville Marie Joseph Mau De |
Method and apparatus for filling containers
|
|
GB684057A
(en)
|
1949-11-30 |
1952-12-10 |
Stockholms Bryggerier Ab |
Machine of the rotatory table type for the treatment of bottles and the like containers
|
|
US2699718A
(en)
|
1952-04-10 |
1955-01-18 |
Francis X Wright |
Filling apparatus with beverage preparation mechanism
|
|
FR1418965A
(fr)
|
1964-10-14 |
1965-11-26 |
Chelle Ets |
Tireuse de liquides à double utilisation
|
|
AU554222B2
(en)
|
1981-10-13 |
1986-08-14 |
Toyo Garasu K.K. |
Inspecting glass containers
|
|
EP0464638B1
(de)
|
1990-07-02 |
1997-04-02 |
Hoechst Aktiengesellschaft |
Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-Internucleotidverknüpfungen
|
|
EP1253199A1
(en)
|
1993-09-02 |
2002-10-30 |
Ribozyme Pharmaceuticals, Inc. |
Abasic moieties containing enzymatic nucleic acids
|
|
WO1995026204A1
(en)
|
1994-03-25 |
1995-10-05 |
Isis Pharmaceuticals, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US20030050263A1
(en)
|
1994-07-15 |
2003-03-13 |
The University Of Iowa Research Foundation |
Methods and products for treating HIV infection
|
|
FR2732971B1
(fr)
|
1995-04-13 |
1997-07-04 |
Genset Sa |
Oligonucleotide sens inhibiteur de virus herpes simplex (hsv) a structure en haltere
|
|
US5856462A
(en)
|
1996-09-10 |
1999-01-05 |
Hybridon Incorporated |
Oligonucleotides having modified CpG dinucleosides
|
|
SK284054B6
(sk)
|
1996-10-16 |
2004-08-03 |
Icn Pharmaceuticals, Inc. |
Substituované triazolové nukleozidy, farmaceutický prostriedok s ich obsahom a ich použitie
|
|
DE19648625A1
(de)
|
1996-11-13 |
1998-05-14 |
Soft Gene Gmbh |
Mikroprojektil für das Einbringen von Substanzen in Zellen durch ballistischen Transfer
|
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
|
US6251666B1
(en)
|
1997-03-31 |
2001-06-26 |
Ribozyme Pharmaceuticals, Inc. |
Nucleic acid catalysts comprising L-nucleotide analogs
|
|
US6589940B1
(en)
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
|
US6192481B1
(en)
|
1998-08-18 |
2001-02-20 |
International Business Machines Corporation |
Structure and method for power sequencing of disk drives in a computer system
|
|
AU2457100A
(en)
|
1999-02-26 |
2000-09-14 |
Chiron S.P.A. |
Enhancement of bactericidal activity of neisseria antigens with oligonucleotidescontaining cg motifs
|
|
US6977245B2
(en)
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
US6737066B1
(en)
|
1999-05-06 |
2004-05-18 |
The Immune Response Corporation |
HIV immunogenic compositions and methods
|
|
ES2250151T3
(es)
|
1999-06-29 |
2006-04-16 |
Glaxosmithkline Biologicals S.A. |
Uso de cpg como adyuvante de vacuna contra vih.
|
|
DE19935756A1
(de)
*
|
1999-07-27 |
2001-02-08 |
Mologen Forschungs Entwicklung |
Kovalent geschlossenes Nukleinsäuremolekül zur Immunstimulation
|
|
AU1656601A
(en)
|
1999-11-12 |
2001-06-12 |
Isis Pharmaceuticals, Inc. |
Gapped oligomers having site specific chiral phosphorothioate internucleoside linkages
|
|
EP2292632A3
(en)
|
2000-09-26 |
2012-07-25 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
|
|
DE10290185D2
(de)
|
2001-01-31 |
2004-04-15 |
Mologen Forschungs Entwicklung |
Tumorvakzine
|
|
JP2005504020A
(ja)
|
2001-07-03 |
2005-02-10 |
アイシス・ファーマシューティカルス・インコーポレーテッド |
ヌクレアーゼ耐性キメラオリゴヌクレオチド
|
|
DK1432439T3
(da)
|
2001-10-02 |
2006-04-03 |
Mologen Ag |
Middel til forbedring af immunsvaret
|
|
CN1564867B
(zh)
|
2001-10-02 |
2010-05-12 |
莫洛根股份公司 |
治疗利什曼原虫感染的dna表达构建体
|
|
US7276489B2
(en)
|
2002-10-24 |
2007-10-02 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
|
|
WO2003035836A2
(en)
|
2001-10-24 |
2003-05-01 |
Hybridon Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
|
|
JP2003204793A
(ja)
|
2002-01-15 |
2003-07-22 |
Takeda Chem Ind Ltd |
ウイルス性疾患の予防または治療剤
|
|
DE10211558A1
(de)
|
2002-03-15 |
2003-10-09 |
Noxxon Pharma Ag |
Neue Formen RNAi
|
|
US7605138B2
(en)
*
|
2002-07-03 |
2009-10-20 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
WO2004041183A2
(en)
|
2002-11-01 |
2004-05-21 |
The Regents Of The University Of California |
Methods of treating pulmonary fibrotic disorders
|
|
US8158768B2
(en)
|
2002-12-23 |
2012-04-17 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
|
US7501503B2
(en)
|
2002-12-31 |
2009-03-10 |
Mcgill University |
Compositions and methods for inhibiting RNase H activity of retroid reverse transcriptase
|
|
CN101675993A
(zh)
|
2003-03-26 |
2010-03-24 |
赛托斯生物技术公司 |
Melan-a肽类似物-病毒样颗粒偶联物
|
|
ATE340264T1
(de)
|
2003-06-10 |
2006-10-15 |
Mologen Ag |
Zirkuläres expressionskonstrukt für gentherapeutische anwendungen
|
|
NZ546275A
(en)
|
2003-10-30 |
2009-05-31 |
Coley Pharm Gmbh |
C-class oligonucleotides analogs with enhanced immunostimulatory potency
|
|
US7378509B2
(en)
|
2003-12-02 |
2008-05-27 |
Anesiva, Inc. |
NF-kappaB oligonucleotide decoy molecules
|
|
WO2005063280A1
(de)
|
2003-12-30 |
2005-07-14 |
Mologen Ag |
Allogenes tumortherapeutikum
|
|
EP1716234B1
(de)
|
2004-02-20 |
2013-10-02 |
Mologen AG |
Substituiertes, nicht-kodierendes nukleinsäuremolekül zur therapeutischen und prophylaktischen immunstimulation in menschen und höheren tieren
|
|
JP3976742B2
(ja)
|
2004-02-27 |
2007-09-19 |
江守商事株式会社 |
インターフェロンアルファを誘導する免疫刺激オリゴヌクレオチド
|
|
US20090004703A1
(en)
|
2004-05-28 |
2009-01-01 |
Mologen Ag |
Method for the Production of Suitable Dna Constructs for Specific Inhibition of Gene Expression by Rna Interference
|
|
BRPI0512110A
(pt)
|
2004-06-15 |
2007-10-23 |
Idera Pharmaceutical Inc |
multìmeros de oligonucleotìdeos imunoestimulatórios
|
|
WO2006015560A1
(de)
|
2004-08-09 |
2006-02-16 |
Mologen Ag |
Immunmodulierendes mittel in verbindung mit chemotherapeutischen massnahmen
|
|
US7879992B2
(en)
|
2005-01-31 |
2011-02-01 |
Isis Pharmaceuticals, Inc. |
Modification of MyD88 splicing using modified oligonucleotides
|
|
WO2006091591A1
(en)
|
2005-02-22 |
2006-08-31 |
The Regents Of The University Of California |
Methods of treating gastrointestinal inflammation
|
|
AU2006241149A1
(en)
|
2005-04-26 |
2006-11-02 |
Coley Pharmaceutical Gmbh |
Modified oligoribonucleotide analogs with enhanced immunostimulatory activity
|
|
EA200801045A1
(ru)
|
2005-10-12 |
2008-10-30 |
Кэнсер Рисерч Текнолоджи Лтд. |
Способы и композиции для лечения иммунных нарушений
|
|
ES2544877T3
(es)
|
2005-10-12 |
2015-09-04 |
Idera Pharmaceuticals |
Compuestos oligonucleótidos inmuno reguladores (IRO) para modular la respuesta inmune basada en receptor semejante a Toll
|
|
KR20080075107A
(ko)
|
2005-11-11 |
2008-08-14 |
화이자 인코포레이티드 |
면역조절성 올리고데옥시뉴클레오티드를 사용하는 조합물및 방법
|
|
WO2007062107A2
(en)
|
2005-11-25 |
2007-05-31 |
Coley Pharmaceutical Gmbh |
Immunostimulatory oligoribonucleotides
|
|
EP1951870B1
(de)
|
2005-11-25 |
2013-04-24 |
Mologen AG |
Dna-konstrukte zur spezifischen hemmung der genexpression durch rna-interferenz
|
|
MX2008009970A
(es)
|
2006-02-01 |
2008-11-19 |
Univ Johns Hopkins |
Conjugados de polipeptido-acido nucleico para inmunoprofilaxis o inmunoterapia para desordenes neoplasicos o infecciosos.
|
|
CN101490257A
(zh)
*
|
2006-05-11 |
2009-07-22 |
莫洛根股份公司 |
用于免疫刺激的多聚体
|
|
US20100130593A1
(en)
|
2006-06-13 |
2010-05-27 |
Bayhill Therapeutics, Inc. |
Methods and immune modulator nucleic acid compositions for preventing and treating disease
|
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
EP2468300B1
(en)
|
2006-09-26 |
2017-12-20 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
US20080260820A1
(en)
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
|
AU2008262478B9
(en)
|
2007-05-29 |
2014-06-19 |
Aldevron, L.L.C. |
Vectors and methods for genetic immunization
|
|
HUE025636T2
(en)
|
2007-07-27 |
2016-04-28 |
Immatics Biotechnologies Gmbh |
Novel immunogenic epitopes for immunotherapy
|
|
WO2009035554A2
(en)
|
2007-09-07 |
2009-03-19 |
University Of Florida Research Foundation, Inc. |
Superior structure stability and selectivity of hairpin nucleic acid probes with an l-dna stem
|
|
CN101820908A
(zh)
|
2007-10-09 |
2010-09-01 |
科利制药公司 |
包含改性糖部分的免疫刺激寡核苷酸类似物
|
|
EP2058397A1
(de)
|
2007-11-07 |
2009-05-13 |
Mologen AG |
Multimeres Assemblat zur Immunstimulation
|
|
JP5359883B2
(ja)
|
2007-11-28 |
2013-12-04 |
東レ株式会社 |
肝炎の治療剤又は予防剤
|
|
WO2009069447A1
(ja)
|
2007-11-28 |
2009-06-04 |
Toray Industries, Inc. |
インフルエンザワクチン用のアジュバント及びインフルエンザワクチン
|
|
WO2010039137A1
(en)
|
2008-10-02 |
2010-04-08 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
|
|
EP2246433A1
(de)
|
2009-04-30 |
2010-11-03 |
Mologen AG |
Concatemere zur Immunmodulation
|
|
MX2012011189A
(es)
|
2010-03-26 |
2013-02-07 |
Glaxosmithkline Biolog Sa |
Vacuna contra el virus e inmunodeficiencia humana.
|
|
GB201021873D0
(en)
|
2010-12-23 |
2011-02-02 |
Mologen Ag |
DNA expression construct
|
|
GB201021867D0
(en)
*
|
2010-12-23 |
2011-02-02 |
Mologen Ag |
Non-coding immunomodulatory DNA construct
|
|
JP5761707B2
(ja)
|
2011-02-02 |
2015-08-12 |
国立研究開発法人産業技術総合研究所 |
高効率細胞融合法
|
|
EP2744830A4
(en)
*
|
2012-06-21 |
2015-06-17 |
Compugen Ltd |
LSR ANTIBODIES AND USES THEREOF FOR THE TREATMENT OF CANCER
|
|
GB2514591A
(en)
|
2013-05-30 |
2014-12-03 |
Mologen Ag |
Predictive biomarker for cancer therapy
|
|
GB2523187A
(en)
*
|
2014-02-18 |
2015-08-19 |
Mologen Ag |
Covalently closed non-coding immunomodulatory DNA construct
|
|
LU92821B1
(en)
|
2015-09-09 |
2017-03-20 |
Mologen Ag |
Combination comprising immunostimulatory oligonucleotides
|
|
GB2542425A
(en)
|
2015-09-21 |
2017-03-22 |
Mologen Ag |
Means for the treatment of HIV
|
|
EP3392345A1
(en)
|
2017-04-22 |
2018-10-24 |
Mologen AG |
Biomarker for small cell lung cancer therapy
|
|
SG11202001683SA
(en)
|
2017-08-31 |
2020-03-30 |
Mologen Ag |
Tlr-9 agonists for modulation of tumor microenvironment
|